🚀 ProPicks AI Hits +34.9% Return!Read Now

Amgen Options Traders Betting On Stock Rising This Much By April Expiration

Published 30/03/2023, 13:30
© Reuters.  Amgen Options Traders Betting On Stock Rising This Much By April Expiration
AMGN
-
AMGN34
-

Benzinga - Within the next month, Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.

On CNBC’s "Options Action," Kelly Intelligence's Kevin Kelly said there were 1.84x more calls than puts on Amgen on Wednesday.

Don’t forget to check out our premarket coverage here

There was a buyer of 125 of the April 245-calls at an average price of $2.30 per contract, Kelly explained, adding that Amgen’s stock will gain at least 3% by April expiration.

Amgen recently announced plans to cut 450 jobs, or lower than 2% of its workforce. As of Dec. 31, 2022, the Thousand Oaks, California-based company had approximately 25,200 employees in over 50 countries.

Price Action: Amgen shares gained 1.1% to settle at $241.03 on Wednesday and added 0.3% in after-hours trading session.

Check This Out: Top 5 Risk Off Stocks That May Crash In March

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.